Nasal Medication Conveyance Framework: An Approach for Brain Delivery from Essential to Cutting Edge

Authors

  • Dhaval Shah Department of Pharmacy, M.S. University Vadodara, Gujarat, India
  • Vivek Chavda Intas Pharmaceuticals Ltd, Rajkot-Bhavnagar Highway, Matoda, Ahmedabad, Gujarat, India
  • Hemal Tandel Department of Pharmacy, M.S. University Vadodara, Gujarat, India
  • Kaushik Domadiya Department of Pharmaceutics, B.K. Mody Government Pharmacy College, Rajkot, Gujarat, India

DOI:

https://doi.org/10.37591/rrjom.v6i1.1519

Abstract

For the past few years, nasal drug delivery has provided attractive niche to the formulation scientists. It is the first choice as targeted drug delivery when one requires it for brain targeting. In addition, absorption of drug at the olfactory region of the nose provides a potential for a pharmaceutical compound to be available to the central nervous system. The nasal delivery of vaccines is another very attractive application in terms of efficacy and patient acceptance. The use of the nasal route for the delivery of challenging drugs has created much interest in recent years in the pharmaceutical industry. The article is grafted to provide an overview for nasal drug delivery and the factors to be considered while developing nasal drug delivery systems.

 

Keywords: Nasal drug delivery system, Medication, Route of administration

Cite this Article

Dhaval Shah, Vivek Chavda, Hemal Tandel et al. Nasal Medication Conveyance Framework: An Approach for Brain Delivery from Essential to Cutting Edge. Research & Reviews: Journal of Medicine. 2016; 6(1):       14–27p.

Downloads

Published

2019-04-25

Issue

Vol. 6 No. 1 (2016)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.